Online citations, reference lists, and bibliographies.
← Back to Search

The Common Mechanisms Of Sarcopenia And NAFLD

Yu Zhai, Qian Xiao
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Current studies have shown that sarcopenia and nonalcoholic fatty liver disease (NAFLD) have similar pathophysiological profiles. The cooccurrence of sarcopenia and NAFLD has been observed in elderly patients. The actions of these conditions are linked, and their treatments are similar. Therefore, studies should be conducted on NAFLD-sarcopenia rather than on NAFLD or sarcopenia.
This paper references
10.1007/S12603-011-0366-0
Discovering pathways of sarcopenia in older adults: A role for insulin resistance on mitochondria dysfunction
A. Abbatecola (2011)
10.1007/s00125-011-2079-7
Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway
C. Zhang (2011)
10.4254/wjh.v9.i6.326
Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
C. V. Tovo (2017)
10.1507/ENDOCRJ.EJ12-0228
Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.
T. Takamura (2012)
10.1016/j.tem.2016.09.001
Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective
M. Conte (2016)
10.1007/s10620-013-2658-1
No Significant Association Between Vitamin D and Nonalcoholic Fatty Liver Disease in a Chinese Population
L. Li (2013)
10.3945/ajcn.2009.27543
Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia.
E. Wilkes (2009)
10.1002/hep.27134
Is the adiponectin‐AMPK‐mitochondrial axis involved in progression of nonalcoholic fatty liver disease?
S. Dasarathy (2014)
10.1002/hep.24737
Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll‐like receptor activation
C. Roth (2012)
10.1002/hep.29420
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
R. A. Bhanji (2017)
10.1002/hep.26716
Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study
H. Hong (2014)
10.1507/ENDOCRJ.EJ16-0124
The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
Y. Hashimoto (2016)
10.1007/s10735-010-9270-x
Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle
L. Ceglia (2010)
10.1016/S1499-3872(15)60030-3
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
H. Y. Kim (2016)
10.1096/fj.03-1341fje
Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans
C. Guillet (2004)
10.1210/er.2008-0009
Causes and metabolic consequences of Fatty liver.
N. Stefan (2008)
BioMed Research International examination survey III
(2010)
10.1093/ageing/afq034
Sarcopenia: European consensus on definition and diagnosis
A. Cruz-Jentoft (2010)
10.1172/JCI34275
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
C. Postic (2008)
10.1096/fj.05-4607fje
Insulin resistance of muscle protein metabolism in aging
B. Rasmussen (2006)
10.1093/AJCN.82.2.428
Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study.
M. Cesari (2005)
10.2337/db06-1566
Aerobic Exercise Overcomes the Age-Related Insulin Resistance of Muscle Protein Metabolism by Improving Endothelial Function and Akt/Mammalian Target of Rapamycin Signaling
S. Fujita (2007)
10.1111/j.1365-2362.2012.02706.x
Vitamin D attenuates high fat diet–induced hepatic steatosis in rats by modulating lipid metabolism
Y. Yin (2012)
10.1359/jbmr.080420
Vitamin D and Health: Perspectives From Mice and Man
R. Bouillon (2008)
10.1007/s10620-015-3963-7
Prevention of NSAID-Enteropathy: A Soluble Problem?
J. Wallace (2015)
10.1016/j.tem.2008.08.005
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
H. Tilg (2008)
10.1093/jn/127.5.990S
Sarcopenia: origins and clinical relevance.
I. Rosenberg (1997)
10.3748/wjg.v18.i3.237
Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.
M. Hamaguchi (2012)
10.1007/s10620-016-4285-0
Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1
D. Cabrera (2016)
10.1016/S1262-3636(05)73648-X
Insulin resistance: a contributing factor to age-related muscle mass loss?
C. Guillet (2005)
10.1016/j.jamda.2009.09.014
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
M. Cesari (2010)
10.1097/MCO.0b013e32834dd297
Chronic low-grade inflammation and age-related sarcopenia
I. Beyer (2012)
10.1111/apt.12377
Meta‐analysis: vitamin D and non‐alcoholic fatty liver disease
M. Eliades (2013)
10.1210/JC.2003-030604
Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.
M. Visser (2003)
10.1371/journal.pone.0145811
Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
E. Poggiogalle (2016)
10.1186/1741-7015-9-85
Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
I. Barchetta (2011)
10.1016/j.mam.2008.07.002
Vitamin D and skeletal muscle tissue and function.
L. Ceglia (2008)
10.1371/journal.pone.0010805
Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III
P. Srikanthan (2010)
10.1016/j.jhep.2015.02.051
Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Y. Lee (2015)
Insulin resistance: A contributing factor to age-relatedmuscle mass loss?”Diabetes &Metabolism
C. Guillet (2005)
10.1210/JC.2006-0587
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
K. Utzschneider (2006)
10.1111/j.1365-2265.2010.03858.x
A prospective study of the associations between 25‐hydroxy‐vitamin D, sarcopenia progression and physical activity in older adults
D. Scott (2010)
10.1016/j.jhep.2010.12.026
Shedding new light on vitamin D and fatty liver disease.
A. Geier (2011)
10.1159/000318741
Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
A. Wree (2010)
10.1007/s00125-015-3751-0
Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis
Haitham A. Abdulla (2015)
10.1136/gut.2003.037010
Adiponectin and its receptors in non-alcoholic steatohepatitis
S. Kaser (2005)
10.1093/aje/kws448
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.
M. Lazo (2013)
10.1007/s00125-009-1430-8
Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism
S. Fujita (2009)
10.1210/en.2011-0159
1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells.
L. García (2011)
Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the national health and nutrition 4 BioMed Research International examination survey III
P. Srikanthan (2010)
10.1016/j.bbrc.2014.05.145
Active vitamin D possesses beneficial effects on the interaction between muscle and bone.
K. Tanaka (2014)
10.1111/j.1532-5415.2012.03887.x
Association Between Visceral Obesity and Sarcopenia and Vitamin D Deficiency in Older Koreans: The Ansan Geriatric Study
J. A. Seo (2012)
10.1210/me.2013-1048
Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity.
S. Bonala (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar